Vietnam’s healthcare sector continues to attract significant attention from global investors, as the country’s rapidly growing population, expanding middle class, and increasing demand for high-quality healthcare services create lucrative opportunities. In 2024, several landmark transactions have further highlighted the sector’s potential, ranging from hospital acquisitions to strategic partnerships and equity investments. Below are five notable healthcare investment deals that are shaping the future of healthcare in Vietnam.
1. Thomson Medical Group’s Acquisition of FV Hospital
In one of the largest transactions in Vietnam’s healthcare sector, Thomson Medical Group, a Singapore-based private healthcare provider, acquired FV Hospital for US$381.4 million in January 2024. FV Hospital, located in Ho Chi Minh City, is one of Vietnam’s leading private hospitals offering comprehensive healthcare services across multiple specialties.
The acquisition is part of Thomson Medical’s strategy to expand its footprint in Southeast Asia, particularly in high-growth markets like Vietnam, where demand for quality private healthcare is on the rise. This deal not only strengthens Thomson Medical’s position in the region but also underscores the potential of Vietnam’s private healthcare market, which continues to grow rapidly as more people seek better healthcare options.
-
Transaction Value: $381.4 million
-
Impact: Enhances Thomson Medical’s presence in Vietnam, broadening its healthcare offerings and expanding its ability to provide high-quality medical services to a growing consumer base.
2. Warburg Pincus’ Investment in Xuyen A Healthcare System
In April 2024, Warburg Pincus, a leading global private equity firm, made a significant investment in Xuyen A, a well-established private tertiary general hospital chain in Vietnam. Xuyen A operates four large-format, multi-specialty hospitals primarily in Southern Vietnam, catering to a wide range of healthcare needs from general medicine to specialized treatments.
This strategic investment will allow Xuyen A to expand its hospital network, increase its capacity, and enhance the quality of services it offers to patients. Vietnam’s healthcare sector is seeing increasing investments in private hospitals and medical centers as the demand for advanced treatments rises. With Warburg Pincus’s support, Xuyen A is poised to become a major player in the country’s healthcare landscape.
-
Transaction Value: Undisclosed
-
Impact: Supports the expansion of private healthcare infrastructure, enabling Xuyen A to reach more patients and improve healthcare services in Southern Vietnam.
3. CVC Capital’s Acquisition of Phuong Chau International Hospital
In 2024, CVC Capital, a global private equity firm, acquired a significant stake in Phuong Chau International Hospital for US$116 million. Phuong Chau is a leading private hospital based in Vietnam’s Mekong Delta, a region with a growing demand for high-quality medical services.
This acquisition reflects CVC Capital’s confidence in Vietnam’s healthcare market, particularly in underserved regions like the Mekong Delta. Phuong Chau International Hospital offers specialized services such as fertility treatments, cardiovascular care, and high-quality diagnostic services, attracting both local and international patients. The investment will enable Phuong Chau to enhance its services, expand its facilities, and increase its reach across the region.
-
Transaction Value: $116 million
-
Impact: Expands healthcare access in the Mekong Delta, improving medical infrastructure and care quality in the region.
4. Raffles Medical Group’s Partnership with American International Hospital
Raffles Medical Group, a leading healthcare provider based in Singapore, entered into a comprehensive strategic partnership with American International Hospital (AIH) in Hanoi in October 2023. The collaboration aims to enhance healthcare services and expand the medical facilities in Vietnam, addressing the growing demand for quality healthcare in the capital city.
This partnership is particularly important as it brings Raffles Medical’s expertise in healthcare management, medical technology, and patient care to Vietnam. AIH, which is known for its high-quality medical services, will benefit from Raffles Medical’s global experience, enabling it to enhance its services and further establish itself as a leading healthcare provider in the country.
-
Transaction Value: Undisclosed
-
Impact: Strengthens healthcare infrastructure in Hanoi and expands service offerings, improving the overall healthcare landscape in Northern Vietnam.
5. Dongwha Pharm’s Acquisition of Stake in Trung Son Pharma
In a move to expand its reach in the Vietnamese pharmaceutical market, Dongwha Pharm, a South Korean pharmaceutical company, acquired a 51% stake in Trung Son Pharma, a Vietnamese pharmaceutical manufacturer, for an undisclosed amount. Trung Son Pharma is known for producing over-the-counter (OTC) medications, as well as manufacturing and distributing prescription drugs in Vietnam.
The acquisition will help Dongwha Pharm tap into Vietnam’s growing demand for pharmaceutical products, particularly in the fields of OTC drugs and generics. With the rise of chronic diseases and an increasing demand for affordable medications, Vietnam’s pharmaceutical market presents significant growth opportunities. Dongwha’s entry into the market will enhance the local distribution of pharmaceutical products and help meet the needs of the country’s expanding healthcare sector.
-
Transaction Value: Undisclosed
-
Impact: Strengthens Dongwha Pharm’s presence in the Southeast Asian pharmaceutical market, particularly in Vietnam.
Conclusion
The healthcare sector in Vietnam continues to evolve with increasing investment from both local and international private equity firms. These notable deals reflect the growing interest in Vietnam’s healthcare market, driven by the country’s expanding population, rising middle class, and demand for high-quality medical services. From hospital acquisitions to strategic partnerships, these investments are setting the stage for a transformative period in Vietnam’s healthcare industry, improving access, expanding infrastructure, and enhancing the quality of care available to the population.
As the sector continues to grow, private equity remains a crucial avenue for funding healthcare infrastructure and services in Vietnam. At DealFlow.sg, we specialize in connecting global investors with high-potential opportunities in Vietnam, providing insights and expertise to navigate the evolving healthcare landscape.
